OPTIMIZING TREATMENT WITH LURASIDONE IN PATIENTS WITH SCHIZOPHRENIA: RESULTS OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL

被引：0
|
作者：
Loebel, Antony [1 ,2 ]
Silva, Robert [1 ,2 ]
Goldman, Robert [1 ,2 ]
Watabbe, Kei [1 ,2 ]
Pikalov, Andrei [1 ,2 ]
Cucchiaro, Josephine [1 ,2 ]
Kane, John M. [3 ]
机构：
[1] Sunov Pharmaceut Inc, Clin Dev & Med Affairs, Marlborough, MA USA
[2] Sunov Pharmaceut Inc, Clin Dev & Med Affairs, Ft Lee, NJ USA
[3] Hofstra North Shore LIJ Sch Med, Psychiat & Mol Med, Uniondale, NY USA
来源：
SCHIZOPHRENIA BULLETIN | 2015年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
2114720
引用
收藏
页码：S321 / S321
页数：1
相关论文
共 50 条
  • [1] Optimizing Treatment with Lurasidone in Patients with Schizophrenia: Results: of a Randomized, Double-blind, Placebo-controlled Trial (OPTIMIZE Trial)
    Loebel, Antony
    Silva, Robert
    Goldman, Robert
    Watabe, Kei
    Cucchiaro, Josephine
    Kane, John
    NEUROPSYCHOPHARMACOLOGY, 2014, 39 : S476 - S477
  • [2] Lurasidone in the treatment of schizophrenia: Results of a double-blind, placebo-controlled trial in Asian patients
    Higuchi, Teruhiko
    Ishigooka, Jun
    Iyo, Masaomi
    Yeh, Chin-Bin
    Ebenezer, Esther Gunaseli
    Liang, Kuei Yu
    Lee, Jung Sik
    Lee, Sang Yeol
    Lin, Shih Ku
    Yoon, Bo-Hyun
    Nakamura, Masatoshi
    Hagi, Katsuhiko
    Sato, Takayuki
    ASIA-PACIFIC PSYCHIATRY, 2019, 11 (02)
  • [3] EFFICACY OF LOW DOSE LURASIDONE IN PATIENTS WITH SCHIZOPHRENIA: RESULTS OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
    Kane, John M.
    Silva, Robert
    Goldman, Robert
    Watabe, Kei
    Cucchiaro, Josephine
    Loebel, Antony
    SCHIZOPHRENIA BULLETIN, 2015, 41 : S317 - S317
  • [4] Lurasidone in the Treatment of Acute Schizophrenia: A Double-Blind, Placebo-Controlled Trial
    Nakamura, Mitsutaka
    Ogasa, Masaaki
    Guarino, John
    Phillips, Debra
    Severs, Joseph
    Cucchiaro, Josephine
    Loebel, Antony
    JOURNAL OF CLINICAL PSYCHIATRY, 2009, 70 (06) : 829 - 836
  • [5] LURASIDONE IN THE TREATMENT OF ACUTE SCHIZOPHRENIA: RESULTS OF THE DOUBLE-BLIND, PLACEBO-CONTROLLED PEARL 2 TRIAL
    Meltzer, Herbert Y.
    Cucchiaro, Josephine
    Silva, R.
    Ogasa, M.
    Phillips, D.
    Xu, J.
    Kalali, A. H.
    Loebel, A.
    SCHIZOPHRENIA BULLETIN, 2011, 37 : 315 - 315
  • [6] LURASIDONE IN THE TREATMENT OF ACUTE SCHIZOPHRENIA: RESULTS OF THE DOUBLE-BLIND, PLACEBO-CONTROLLED PEARL 2 TRIAL
    Cucchiaro, Josephine
    Silva, Robert
    Ogasa, Masaaki
    Xu, Jane
    Phillips, Debra
    Simonelli, Doreen
    Kalali, Amir
    Loebel, Antony
    Meltzer, Herbert
    SCHIZOPHRENIA RESEARCH, 2010, 117 (2-3) : 493 - 493
  • [7] Daytime sleepiness associated with lurasidone and quetiapine XR: results from a randomized double-blind, placebo-controlled trial in patients with schizophrenia
    Loebel, Antony D.
    Siu, Cynthia O.
    Cucchiaro, Josephine B.
    Pikalov, Andrei A.
    Harvey, Philip D.
    CNS SPECTRUMS, 2014, 19 (02) : 197 - 205
  • [8] A double-blind, placebo-controlled, randomized withdrawal study of lurasidone for the maintenance of efficacy in patients with schizophrenia
    Tandon, R.
    Loebel, A.
    Phillips, D.
    Pikalov, A.
    Hernandez, D.
    Mao, Y.
    Cucchiaro, J.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2014, 17 : 153 - 154
  • [9] A DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED WITHDRAWAL STUDY OF LURASIDONE FOR THE MAINTENANCE OF EFFICACY IN PATIENTS WITH SCHIZOPHRENIA
    Tandon, Rajiv
    Loebel, Antony
    Phillips, Debra
    Pikalov, Andrei
    Hernandez, David
    Mao, Yongcai
    Cucchiaro, Josephine
    SCHIZOPHRENIA RESEARCH, 2014, 153 : S372 - S372
  • [10] A double-blind, placebo-controlled, randomized withdrawal study of lurasidone for the maintenance of efficacy in patients with schizophrenia
    Tandon, Rajiv
    Cucchiaro, Josephine
    Phillips, Debra
    Hernandez, David
    Mao, Yongcai
    Pikalov, Andrei
    Loebel, Antony
    JOURNAL OF PSYCHOPHARMACOLOGY, 2016, 30 (01) : 69 - 77
12345